Montco biopharm firm gets $9M grant to battle China's new coronavirus 
 The Coalition for Epidemic Preparedness Innovations (CEPI) has awarded a $9 million grant to Inovio Pharmaceuticals to support development of a vaccine against the recently emerged strain of coronavirus.

The new coronavirus strain has killed 17 people, and infected nearly 600 more, in China.

The CEPI funding will support Inovio’s preclinical and clinical development, through phase-I human testing, of INO-4800 – the Plymouth Meeting company's new potential coronavirus vaccine matched to the…